Japanese drugmaker Takeda Pharmaceutical announced on Thursday that it agreed to acquire Swiss rival Nycomed for roughly $13.7 billion in an effort to expand its presence in Europe and emerging markets.
Featured Firms
Presented by BigVoodoo
Freshfields Bruckhaus Deringer, White & Case, CMS Cameron McKenna and Edwards Angell Palmer & Dodge are advising on the Japanese pharmaceuticals company's acquisition of its Swiss rival, The AmLaw Daily reports.
May 20, 2011 at 12:00 AM
1 minute read
Japanese drugmaker Takeda Pharmaceutical announced on Thursday that it agreed to acquire Swiss rival Nycomed for roughly $13.7 billion in an effort to expand its presence in Europe and emerging markets.
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Honoring outstanding legal achievements focused at the national level, largely around Big Law and in-house departments.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS